Financial results - NEURODIAB NĂSTASE S.R.L.

Financial Summary - Neurodiab Năstase S.r.l.
Unique identification code: 41400381
Registration number: J2019000811398
Nace: 8622
Sales - Ron
76.350
Net Profit - Ron
39.780
Employees
1
Open Account
Company Neurodiab Năstase S.r.l. with Fiscal Code 41400381 recorded a turnover of 2024 of 76.350, with a net profit of 39.780 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Neurodiab Năstase S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 19.926 56.803 55.123 63.714 68.980 76.350
Total Income - EUR - - - - 19.926 56.803 55.183 63.716 69.924 76.350
Total Expenses - EUR - - - - 7.100 18.121 25.092 24.567 33.501 34.279
Gross Profit/Loss - EUR - - - - 12.827 38.682 30.091 39.148 36.423 42.071
Net Profit/Loss - EUR - - - - 12.229 37.068 28.436 37.237 35.724 39.780
Employees - - - - 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 11.3%, from 68.980 euro in the year 2023, to 76.350 euro in 2024. The Net Profit increased by 4.256 euro, from 35.724 euro in 2023, to 39.780 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Neurodiab Năstase S.r.l.

Rating financiar

Financial Rating -
NEURODIAB NĂSTASE S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Neurodiab Năstase S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neurodiab Năstase S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Neurodiab Năstase S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neurodiab Năstase S.r.l. - CUI 41400381

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 42.123 48.105 36.043 24.518 13.305 5.614
Current Assets - - - - 9.876 18.899 14.262 13.601 23.831 37.572
Inventories - - - - 0 868 0 0 0 563
Receivables - - - - 217 424 530 13 1.691 2.463
Cash - - - - 9.659 17.607 13.733 13.588 22.139 34.547
Shareholders Funds - - - - 12.271 49.106 49.854 37.416 35.764 39.821
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 39.729 17.898 451 703 1.372 3.365
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 37.572 euro in 2024 which includes Inventories of 563 euro, Receivables of 2.463 euro and cash availability of 34.547 euro.
The company's Equity was valued at 39.821 euro, while total Liabilities amounted to 3.365 euro. Equity increased by 4.257 euro, from 35.764 euro in 2023, to 39.821 in 2024.

Risk Reports Prices

Reviews - Neurodiab Năstase S.r.l.

Comments - Neurodiab Năstase S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.